Archives: Publications
Desmoplastic Small Round Cell Tumor Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Results of a Phase 2 Trial
Andrea A. Hayes-Jordan, MD, Brian A. Coakley, MD, Holly L. Green, PA-C, LianChun Xiao, MS, Keith F. Fournier, MD, Cynthia E. Herzog, MD, Joseph A. Ludwig, MD, Mary F. McAleer, MD PhD, Peter M. Anderson, MD PhD, and Winston W. Huh, MD
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A safe treatment option for intraperitoneal rhabdomyosarcoma in children below 5 years of age
Jens Gesche, Stefan Beckert, Felix Neunhoeffer, Denis Kachanov, Alfred Königsrainer, Guido Seitz, Jörg Fuchs
Cytoreductive surgery and hyperthermic intraperitoneal perfusion with chemotherapy in children with peritoneal tumor spread: A French nation wide study over 14 years
Aurélien Scalabre , Pascale Philippe-Chomette, Guillaume Passot, Daniel Orbach , Dominique Elias, Nadège Corradini, Laurence Brugières, Simon Msika, Marc-David Leclair, Solène Joseph, Cécile Brigand, François Becmeur, Christine Soler, Denis Pezet, Johan Gagniere, Olivier Glehen, Sabine Sarnacki
The Role of Hyperthermic Intraperitoneal Chemotherapyin Pseudomyxoma Peritonei After Cytoreductive Surgery
Shigeki Kusamura, MD, PhD; Francesco Barretta, PhD; Yutaka Yonemura, MD, PhD; Paul Hendrick Sugarbaker, MD; Brendan John Moran, MCh;Edward A. Levine, MD; Diane Goere, MD, PhD; Dario Baratti, MD; Eran Nizri, MD, PhD; David Lawson Morris, MB, ChB, MD, PhD; Olivier Glehen, MD, PhD;Armando Sardi, MD; Pedro Barrios, MD; François Quénet, MD, PhD; Laurent Villeneuve, MBE, PhD; Alberto Gómez-Portilla, MD, PhD;Ignace de Hingh, MD, PhD; Wim Ceelen, MD, PhD; Joerg O. W. Pelz, MD; Pompiliu Piso, MD, PhD; Santiago González-Moreno, MD, PhD;Kurt Van Der Speeten, MD, PhD; Marcello Deraco, MD;
Referral and treatment pathways for pseudomyxoma peritonei of appendiceal origin within a national treatment programme
Rebecca Fish, Andrew G Renehan, Grant Punnett, Omer Aziz, Paul Fulford, Chelliah Selvasekar, Malcolm Wilson, Rebecca Halstead, Sarah T. O’Dwyer
Long-term survival after aggressive treatment of relapsedserosal or distant pseudomyxoma peritonei
J.-B. Delhorme, C. Honore, L. Benhaim, F. Dumont, ,P. Dartigues, C. Dromain, M. Ducreux, D. Elias, D.Goer
Outcome differences between debulking surgery and cytoreductive surgeryin patients with pseudomyxoma peritonei
H. Andreasson, W. Graf, P. Nygren, B. Glimelius,c, H. Mahteme
Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Terence C. Chua, Brendan J. Moran, Paul H. Sugarbaker, Edward A. Levine, Olivier Glehen, Franc ois N. Gilly, Dario Baratti, Marcello Deraco, Dominique Elias, Armando Sardi, Winston Liauw, Tristan D. Yan,Pedro Barrios, Alberto Gomez Portilla, Ignace H.J.T. de Hingh, Wim P. Ceelen, Joerg O. Pelz, Pompiliu Piso, Santiago Gonzalez-Moreno, Kurt Van Der Speeten, and David L. Morris
Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy
D. Elias, F. Gilly, F. Quenet, J. M. Bereder, L. Sidéris, B. Mansvelt, G. Lorimier, O. Glehen
Well differentiated papillary peritoneal mesothelioma treated by cytoreduction andhyperthermic intraperitoneal chemotherapy - the experience of the PSOGI registry
Marcello Deraco, Eran Nizri, Olivier Glehen, Dario Baratti, Jean-Jacques Tuech,Jean-Marc Bereder, Vahan Kepenekian, Shigeki Kusamura, Diane Goere